Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$187.49 - $221.1 $2.26 Million - $2.66 Million
-12,040 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $80,530 - $93,869
389 Added 3.34%
12,040 $2.59 Million
Q4 2020

Feb 16, 2021

SELL
$207.01 - $276.09 $678,992 - $905,575
-3,280 Reduced 21.97%
11,651 $2.75 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $415,431 - $492,537
-1,625 Reduced 9.82%
14,931 $4.06 Million
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $64,487 - $84,598
-286 Reduced 1.7%
16,556 $4.81 Million
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $299,655 - $371,715
-1,500 Reduced 8.18%
16,842 $4.01 Million
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $3.06 Million - $4.11 Million
18,342 New
18,342 $4.02 Million
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $684,867 - $770,810
-4,120 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $207,737 - $240,246
1,262 Added 44.16%
4,120 $756,000
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $121,323 - $144,272
741 Added 35.0%
2,858 $526,000
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $91,297 - $115,518
601 Added 39.64%
2,117 $351,000
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $254,278 - $292,193
1,516 New
1,516 $292,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.